Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Status Recruiting

Clinical Trial Summary

Zoledronic acid is an adjuvant treatment for primary osteosarcoma. Zoledronic acid has been widely used in the treatment of metastatic bone tumors. In addition to its inhibition of tumor osteoclasis, it also produces certain killing of tumor cells. effect. Foreign studies have shown that zoledronic acid also has a killing effect on osteosarcoma and has a certain inhibitory effect on distant metastasis. We hope that it can reduce tumor recurrence and lung metastasis through this study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03932071
Study type	Interventional
Source	Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact	Xiaobo Yan, Dr.
Phone	+8613588153306
Email	yanxiaobo82@gmail.com
Status	Recruiting
Phase	Phase 4
Start date	January 1, 2017
Completion date	January 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02107755` - Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma	Phase 2
Recruiting	`NCT06145048` - Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.	Phase 2
Recruiting	`NCT05375591` - AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer
Recruiting	`NCT04684186` - Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung Cancer
Completed	`NCT00528645` - AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer	Phase 2
Recruiting	`NCT03944798` - Surveillance AFter Extremity Tumor surgerY	N/A
Recruiting	`NCT04940936` - Shared Decision Making on Radiation Dose for Lung Malignancies	N/A
Recruiting	`NCT04455438` - SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions	N/A
Completed	`NCT00030667` - Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood	Phase 2
Active, not recruiting	`NCT03108677` - Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma
Withdrawn	`NCT01325753` - Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body	N/A
Recruiting	`NCT05755672` - On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Active, not recruiting	`NCT01706432` - Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
Not yet recruiting	`NCT04888806` - A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis	Phase 2
Recruiting	`NCT06321640` - Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
Completed	`NCT02496585` - Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis	Phase 2
Withdrawn	`NCT01741597` - Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung	Phase 1
Completed	`NCT01621698` - Study of Use of Paravertebral Blocks for Pain Relief in Video Assisted Lung Surgery	N/A
Terminated	`NCT01258634` - A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response	Phase 1
Active, not recruiting	`NCT02226276` - Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer	N/A